Catastrophic Antiphospholipid Syndromes in Systemic Lupus Erythematosus

References

• Alving B M, Barr C F, Tang D B. Correlations between lupus anticoagulant and anticardiolipin antibodies in patients with associated partial thromboplastin time. Am J Med 1990; 88: 112–116
   Google Scholar
• Triplett D A. Antiphospholipid and thrombosis: a consequence, coincidence or cause?. Arch Pathol Lab Med 1993; 117: 78–88
   PubMedGoogle Scholar
• Galli M, Finazzi G, Bevers E M, Barbui T. Kaolin clotting time and dilute Russell's viper venom time distinguish between Prothrombim-dependent and β2-Glicoprotein I-dependent antiphospholipid antibodies. Blood 1995; 86: 617–623
   PubMed Web of Science ®Google Scholar
• Davies K A, Ireland H, Athanassiou P, Loizou S, Lane D, Walport M J. Factor V Leiden mutation and venous thrombosis. Lancet 1995; 345: 132–133
   Google Scholar
• De Groot P G, Derksen R HWM. Protein C pathway, antiphospholipid antibodies and thrombosis. Lupus 1994; 3: 229–233
   Google Scholar
• Violi F, Ferro D, Valesini G. Thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995; 333: 665
   Google Scholar
• Cuadrado M J, Lopez-Pedrera C, Kamashtha M A, Camps M T, Tinahones F, Torres A, Hugues G RV, Velasco F. Thrombosis in primary antiphospholipid syndrome. A pivotal role for monocyte tissue factor expression. Arthritis Rheum 1997; 40: 834–841
   PubMed Web of Science ®Google Scholar
• Harris E N, Gharavi A E, Boey M L, Patel B M, Mackworth-Young C G, Loizou S, Hughes G RV. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 121(ii)1–1214
   Google Scholar
• Jungers P, Liote P, Dautzenberg M D, Gazengel C, Dougados M, Tron F, Bach J F. Lupus anticoagulart and thrombosis in systemic lupus erythematosus. Lancer 1984; i: 574–575
   Google Scholar
• Glueck H I, Kotagal S K, Mark A, Weiss M D, Pollak V E, Miller M A, Coots M. Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants. Arch Intern Med 1985; 145: 1389–1395
   PubMedGoogle Scholar
• Love P E, Santoro S A. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in Systemic Lupus Eqthematosus (SLE and in non-SLE disorders. Ann Int Med 1990; 112: 682–698
   PubMed Web of Science ®Google Scholar
• Vianna J L, Haga H J, Tripathi P, Cervera R, Khamashta M A, Hughes G RV. Reassessing the status of antiphospholipid syndrome in systemic lupus erythema-tosus. Ann Rheum Dis 1992; 51: 160–161
   PubMed Web of Science ®Google Scholar
• Jouhikainen T, Stephansson E, Leirisalo-Repo M. Lupus anticoagulant as a prognostic marker in systemic lupus erythematosus. BrJ Rheum 1993; 32: 568–573
   Google Scholar
• Peck B, Hoffman G S, Franck W A. Trombophlebitis in systemic lupus erythematosus. JAMA 1978; 240: 172–175
   Google Scholar
• Angles-Cano E, Sultan Y, Clavvel J-P. Predisposing factor to thrombosis in systemic lupus erythematosus. Potential relation to endothelial cell damage. J Lab Clin Med 1979; 94: 312–323
   PubMed Web of Science ®Google Scholar
• Gladman D D, Urowitz M B. Venous syndromes and pulmonary embolism in systemic lupus erythematosus. Rheum Dis 1980; 39: 340–343
   Google Scholar
• Sturtfelt G, Nived O, Norberg R, Thorstensson R, Krook K. Anticardio-lipin antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 1987; 30: 382–388
   Google Scholar
• Weidmann C E, Wallace D J, Peter J B, Knight P J, Bear M B, Klinenberg J R. Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus. J Rheumotol 1988; 15: 74–79
   PubMed Web of Science ®Google Scholar
• Frampton G, Hicks J, Cameron J S. Significance of antiphospholipid antibodies in patients with lupus nephritis;. Kidney Int 1991; 39: 1225–1231
   PubMed Web of Science ®Google Scholar
• Moroni G, La Marchesina U, Banfi G, Nador F, Vigano E, Marconi M, Lotto A, Ponticelli C. Cardiologic abnormalities in patients with long-term lupus nephritis. Clin Nephrol 1995; 43: 20–28
   Google Scholar
• Asherson R A. The catastrophic antiphospholipid syndrome. J Rheumatol 1992; 19: 508–512
   PubMed Web of Science ®Google Scholar
• Tan E M, Cohen A S, Fries J F. The revised criteria for the classification of SLE. Arthritis Rheum 1985; 25: 1271–1275
   Google Scholar
• Stratta P, Canavese C, Valmaggia P, Rotunno M, Levi E, Bulla A, Vercellone A. Coagulation and fibrinolysis in systemic Lupus erithematosus. Thromb Haemostas 1981; 46(Stuttgart)575–580
   Google Scholar
• Churg J, Sobin L H. Lupus Nephritis. Renal disesase. Classification and Atlas of Glomerular Diseases, J Churg. Igaku-Shoin, New York, NY 1982; 127–149
   Google Scholar
• Sneddon J B. Cerebro-vascular lesions and livedo reticularis. Br J Dermato 1965; 77: 180–184
   PubMedGoogle Scholar
• Remuzzi G, Ruggenenti P. The hemolytic uremic syndrome. Kidney Int 1995; 47: 2–19
   Web of Science ®Google Scholar
• Rosner E, Pauzner R, Lusky A, Modan M, Many A. Detection and quantitative evaluation of lupus circulating anticoagulant activity. Thromb Haemost 1987; 57: 744–747
   Google Scholar
• Exner T, Rickard K, Kronenberg H. A sensitive test demonstrating lupus anticoagulant and its behavioral patterns. Br J Haematol 1978; 40: 143–151
   PubMed Web of Science ®Google Scholar
• Harris E N. The second international andicardiolipin standardization workshop/the Kingston antiphospholipid antibody study (KAPS) group. Am J Clin Pathol 1990; 94: 476–484
   PubMed Web of Science ®Google Scholar
• Peto R, Pike P, Armitage M. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1–39
   PubMed Web of Science ®Google Scholar
• Ciampi A, Lawless J F, McKinney S M, Singhal K. Regression and recursive partition strategies in the analysis of medical survival data. J Clin Epidemiol 1988; 41: 737–748
   Google Scholar
• Edworthy S M, Zatarain E, Meshane D J, Bloch D A. Analysis of the 1982 ARA lupus criteria data set by recursive partition methodology: new insight into the relative merit of individual criteria. J Rheumatol 1988; 15: 1493–1498
   PubMed Web of Science ®Google Scholar
• Goulet J-R, Mackenzie T, Levinton C, Hayslett J P, Ciampi A, Esdaile J M. The longterm prognosis of lupus nephritis: the impact of disease activity. J Rheumatol 1993; 20: 59–65
   PubMed Web of Science ®Google Scholar
• Stratta P, Canavese C, Thea A, Tognarelli G, Dogliani M, Porcu M C, Garis C, Borchiellini A, Schinco P C, Vercellone A. Clinical implication of antiphospholipid antibodies. In: Systemic Lupus Erythematosus. Contrib. Nephrol Sessa A, Battini Mesoni. Karger, Basel 1992; 99: 123–125
   Google Scholar
• Ishii Y, Kagasawa K, Mayumi T, Niho Y. Clinical impodance of persistence of anticardiolipin antibodies in systemic lupus erythematousus. Ann Rheum Dis 1990; 49: 387–390
   PubMed Web of Science ®Google Scholar
• Farrugia E, Torres V E, Gastineau D, Michet C J, Holley K E. Lupus anticoagulant in systemic lupus erithematosus: a clinical and renal pathological study. Am J Kidney Dis 1992; XX: 463–471
   Google Scholar
• Stratta P, Canavese C, Segoloni G P, Ferrero S, Grill A, Piccoli G. Shaded boundaries between antiphospholipid antibodies syndrome and lupus nephritis: low discriminating power of American Rheumatism Association Criteria? (letter. Clin Nephrol 1997; 47: 138
   Google Scholar
• Zea Mendoza A, Rodriguez Garcia A, Irigoyen Oyarzabal M V, Vazquez Diaz M, Pardo Vigo A, Mampaso F M, Ortuno Mirete J. Anticuerpos anti-fosfolipido en el lupus eritematoso sistemico: incidencia, significacion y relaci6n con la nefritis lupica. Med Clin, Basel 1989; 92: 724–728
   Google Scholar
• Perdiguero M, Boronat M, Marco P, Rivera F. The role of anti-phospholipid antibodies in lupus nephropathy. Nephron 1995; 71: 35–39
   Google Scholar
• Mueh J, Herbst K, Rappaport S. Thrombosis in patients with the lupus anticoagulant. Ann Int Med 1980; 92: 156–159
   PubMed Web of Science ®Google Scholar
• Quereda C, Garcia Otero G, Pardo A, Orte L, Rivera M, Gonzalo A, Pascual J, Ortuno J. Prevalence of antiphospholipid antibodies in nephropathies not due to systemic lupus erythematosus. Am J Kidney Dis 1994; 23: 555–561
   Google Scholar
• Asherson R A, Khamashta M A, Baguley E, Oakley C M, Rowell N R, Hughes G RV. Myocardial infarction and antiphospholipid antibodies in SLE and related disorders. Q. J Med 1989; 272: 1103–1115
   Google Scholar
• Rosove M H, Brewer P MC. Antiphospholipid thrombosis: Clinical course after the first thrombotic evant in 70 patients. Ann Intern Med 1992; 117: 303–308
   PubMed Web of Science ®Google Scholar
• Nicholls K, Kincaid-Smith P. Antiphospholipid syndrome and renal thrombotic microangiopathy. J Nephro1 1995; 8: 123–125
   Google Scholar
• Gelfand J, Truong L, Stem L, Pirani C L, Appel G B. Thrombotic thrombo-cytopenic purpura syndrome in systemic lupus erythematosus: treatment with plasma infusion. Am J Kidney Dis 1985; VI: 154–160
   Google Scholar
• Hughson M D, Nadasdy T, McCarty G A, Sholer C, Min K-W, Silva F. Renal thrombotic microangiopaihy in patients with systemic lupus erythematosus and the antiphospholipid syndrome. An; J Kidney Dis 1992; XX: 150–158
   Google Scholar
• Kwaan H C. Clinicopathologic features of thrombotic thrombocytopenic purpura. Semin Hematol 1987; 24: 71–81
   PubMed Web of Science ®Google Scholar
• Perez R E, McClendon J R, Lie J T. Primary antiphospholipid syndrome with multiorgan arterial and venous thrombosis. J Rheumatot 1992; 19: 1289–1292
   Google Scholar
• Harris E N, Bos K. An acute disseminated coagulopathy-vasculopathy associated with the antyphospholipid syndrome. Arch Intern Med 1991; 151: 231–232
   PubMedGoogle Scholar
• Asherson R A, Baguley E, Pal C, Hughes G RV. Antiphospholipid syndrome: five years follow up. Ann Rheum Dis 1991; 50: 805–810
   Google Scholar
• Derksen R HWM, De Groot P HG, Nieuwenuis H K. Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. Ann Rheum Dis 1993; 52: 689–692
   PubMed Web of Science ®Google Scholar
• Stratta P, Canavese C, Ferrero S, Grill A, Schinco P C, Monta-Ruli B. Failure of the war to the knife against antiphospholipid antibodies by conventional immunosuppressive therapy in systemic lupus erythematosus (letter). Clin Nephrol 1996; 46: 356
   Google Scholar
• Khamashta M A, Cuadrado M J, Mujic F, Taub N A, Hunt B I, Hughes G RV. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995; 332: 993–997
   PubMed Web of Science ®Google Scholar